New medication for male pattern hair loss
Part of Skin clinical trials.
This study tests a new medication called APSMNF for treating male pattern baldness. It aims to see if the medication can help regrow hair safely. Participants will receive either the study medication or a placebo (a dummy treatment) to compare the effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be a man between 18 and 60 years old
- Have typical male pattern baldness diagnosed by a doctor
- Use effective birth control (or have a partner who does) during the study
- Not have other causes of hair loss like patchy baldness or sudden shedding
- Not have scalp conditions like severe dandruff (seborrheic dermatitis), psoriasis, or an active infection at the hair loss area
- Not have a history of allergy to the study medication's ingredients
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 study tests whether a specific hair lotion works and is safe for men with male pattern hair loss. It also checks that results are consistent while you keep similar hair care and avoid certain other hair-loss treatments.
This study tests a new treatment for female pattern hair loss in women aged 18 to 50. It aims to see if the treatment is safe and effective for regrowing hair.
This study tests a new investigational drug, OLX72021, given as injections into the scalp, to see if it can help regrow hair in men with male pattern baldness. It will also check how safe the drug is and how well it works.
This study tests an experimental treatment called EPI-001 for androgenetic alopecia—the most common type of hair loss affecting men and women. Researchers will measure how well it works by tracking hair growth over time using special photography and scalp analysis.
This study tests an investigational topical medication called PP405 for male pattern hair loss. It aims to see if the treatment is safe and effective for regrowing hair in men with moderate balding.
This study tests a new medicine (N1087) to see if it helps women with female pattern hair loss. It compares the study drug to a placebo (a dummy product) to check how well it works and if it's safe.
Hear when a new Alopecia, Androgenetic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.